Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
You don't have permission to view this recording. Please log in or use your personalized link.

The Big Switch: Transitioning Existing Manufacturing to Meet the Challenges of New Technology

Tue, Sep 22, 2020 · 2:00 PM · Eastern Time (US & Canada)
About This Webinar

As the technology practiced in a lab or a manufacturing environment changes, the design and function of the space must change, too. One example of a big change involves gene and cell therapy. Gene and cell therapy are changing the nature of how we look and treat diseases. As more and more manufacturers are getting into this particular sphere of medicine, they are looking at ways to reuse their existing space and make it viable for this important landscape. Jeff Gilmore, PE and Grayson Heller of cGMPnow, along with Alicia Pandimos Maurer, AIA of CannonDesign, will provide specifics on these manufacturing space transitions. The team will discuss the implications of this change on the building and how we as an industry can make this transition in space more seamless and smoother.

Available On Demand Now

Who can view: People who attended or registered for the webinar only
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
Senior Vice President, Science and Technology, CannonDesign
Alicia Pandimos Maurer has more than 20 years of experience in the field of architecture, with her specialty being science and technology. She has worked with both public and private clients. Alicia's passion is for sustainable, human-friendly spaces that look toward the future of science and pharma. Alicia's favorite area of science tech design is gene and cell therapy and its amazing potential for the greater good of humanity. Immunology and DNA/RNA are also very important to her.
Webinar hosting presenter
President/Managing Partner, cGMP Now
Jeff Gilmore has over 26 years of diversified project management, project engineering/process design, scale up/tech transfers, and commissioning/qualification experience. He has a broad range of experience in biopharmaceutical and small molecule API and drug product manufacturing, specialty chemical, and food/beverage industries. Additionally, Jeff has recent and significant experience in the site selection due-diligence, facility design, and manufacturing scale-up of advanced therapeutic medicinal products (ATMPs). He also has supervisory experience of both technical and management staff members and is well-versed in leading multi-disciplinary teams both locally and remotely. He has demonstrated an ability to work in nimble and matrixed team-based environments, lead diverse groups of personnel with and without administrative authority, and has strong problem-solving, organizational, issue resolution, and facilitation skills. He has significant engineering experience associated with fermentation, cell processing, purification, oral solid dosage, plant and process utilities, HVAC, material handling, and facilities equipment/unit operations in cGMP environments.
Webinar hosting presenter
Vice President/Managing Partner, cGMP Now
Grayson Heller has a decade of process/project engineering and project management experience in the pharmaceutical, biotechnology and specialty chemical industries. He earned his ChemE from the University of Colorado and has worked directly for Roche, CH2M Hill, and Sandoz in a variety of roles including system owner.
Attended (58) View all
  • 1599580090-57ba3bd7cc0ad148
  • F
  • P
  • H
  • W
  • 1591650539-064ed69a018702c6
  • D
  • A
  • T
  • A
  • I
  • V
  • J
  • K
  • E
  • Y
  • S